[go: up one dir, main page]

Joisson et al., 1993 - Google Patents

Antigenic analysis of bean pod mottle virus using linear and cyclized synthetic peptides

Joisson et al., 1993

Document ID
13375981987224066724
Author
Joisson C
Kuster F
Plaué S
Van Regenmortel M
Publication year
Publication venue
Archives of virology

External Links

Snippet

The antigenic structure of the comovirus bean pod mottle virus (BPMV) was studied using synthetic peptides selected on the basis of the exposed location of certain regions of the viral protein. Three regions of domain A, four regions of domain B and two regions of domain …
Continue reading at link.springer.com (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/569Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/576Immunoassay; Biospecific binding assay for hepatitis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Similar Documents

Publication Publication Date Title
Trifilieff et al. Antigenic cross-reactivity potential of synthetic peptides immobilized on polyethylene rods
SK7602001A3 (en) Hbv core antigen particles with multiple immunogenic components attached via peptide ligands
JPS60500673A (en) Amino acid sequence with antigenic activity
Daniel et al. Mapping of linear antigenic sites on the S glycoprotein of a neurotropic murine coronavirus with synthetic peptides: a combination of nine prediction algorithms fails to identify relevant epitopes and peptide immunogenicity is drastically influenced by the nature of the protein carrier
JPH0769924A (en) Vaccine composition for herpes simplex virus infective disease
CA2033202A1 (en) Synthetic peptides for diagnosis and prevention of influenza virus infection and their use
PT1881064E (en) Hcv-anti-core monoclonal antibody
Posthumus et al. Analysis and simulation of a neutralizing epitope of transmissible gastroenteritis virus
JP2004525613A (en) Hepatitis E virus polypeptide fragments, vaccine compositions and diagnostic kits containing the same, and uses thereof
Joisson et al. Antigenic analysis of bean pod mottle virus using linear and cyclized synthetic peptides
US20060263765A1 (en) Peptides and mixtures thereof for use in the detection of severe acute respiratory syndrome-associated coronavirus (sars)
JP2818755B2 (en) Novel branched hybrid and cluster peptides useful for diagnosis and detection of non-A non-B hepatitis
JPH02503916A (en) Synthetic peptides related to HIV envelope proteins
Bergmann et al. Hepatitis delta antigen. Antigenic structure and humoral immune response.
CA2144882A1 (en) Synthetic peptide vaccine for chlamydia trachomatis
JP4593780B2 (en) Mimotope of hypervariable part 1 of HCV E2 glycoprotein and use thereof
JPH01224397A (en) Synthetic peptide for detecting hiv antibody and mixture thereof
Mattioli et al. Mimicry of the immunodominant conformation-dependent antigenic site of hepatitis A virus by motifs selected from synthetic peptide libraries
JP3317967B2 (en) Rubella E1 peptide
Irving et al. Exploring peptide mimics for the production of antibodies against discontinuous protein epitopes
Joisson et al. Detection of potyviruses with antisera to synthetic peptides
JPH05508838A (en) Peptides and analogs and mixtures thereof for detecting antibodies to HTLV-I and HTLV-II viruses - Patents.com
JP2000514643A (en) Antigenic epitope of a-determinant of hepatitis B surface antigen and its use
WO1991006562A1 (en) Immunological domains of hepatitis delta virus antigen
Dyrberg et al. Immunological cross-reactivity between mimicking epitopes on a virus protein and a human autoantigen depends on a single amino acid residue